Rosty Raykov - 28 Dec 2023 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)

Role: CHIEF EXECUTIVE OFFICER, Director
Signature: /s/ Rostislav Raykov
Issuer symbol: FENC
Transactions as of: 28 Dec 2023
Net transactions value: -$15,070
Form type: 4
Filing time: 29 Dec 2023, 16:30:19 UTC
Previous filing: 09 Nov 2023
Next filing: 03 Apr 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FENC	Common shares	Options Exercise	$13,579	+8,540	+3%	$1.59^*	291,127	28 Dec 2023	Direct	F1
transaction	FENC	Common shares	Sale	$42,227	-3,656	-1.3%	$11.55	287,471	28 Dec 2023	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	FENC	Commons Shares	Options Exercise	$13,579	+8,540	+3.2%	$1.59^*	271,784	28 Dec 2023	options	8,540	$1.59	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares acquired through the exercise of an option contract with strike price of $1.59 and an expiration date of January 24, 2024.
F2	Shares sold to satisfy tax obligation on option exercise.
F3	Represents options granted on January 24, 2014, with a strike price of $1.59 and an expiration date of January 24, 2024.